Can we predict which hernia repairs will get infected?

NCT ID NCT07790952

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This study investigates what factors may predict mesh infection after open incisional hernioplasty, a surgery to repair a hernia that forms at a previous surgical scar. Researchers will follow 62 patients of any age or gender who have this surgery, tracking who develops a mesh-related infection during follow-up. They will compare patients with and without infection to identify contributing factors. The goal is to better understand why some patients get infections, which could help improve prevention and care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
No drug or device is being tested. The study observes patients who undergo open incisional hernioplasty to identify predictors of mesh infection.
What this could lead to
If it works, this could help doctors identify patients at higher risk of mesh infection after hernia repair, leading to better prevention and care.
What could go wrong
This is a small, single-center study, so the findings may not apply to all patients. It only looks for patterns, not causes, and cannot prove that any factor directly causes infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

62 people

The number who actually took part.

Started

Sep 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient of all age group and both genders with Incisional hernia undergoing open mesh hernioplasty will be consecutively enrolled and followed postoperative to access the development of mesh infection and associated predictors

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. All age group patient will be included 2. Both genders will be involved in this study 3. Incisional hernia as per operational definition Exclusion Criteria: 1. Co- Morbid condition including hypertension, Tuberculosis and Autoimmune disease 2. Parents refusing for consent 3. Immunocompromised patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Predictor of mesh condition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr Faisal Masood teaching Hospital Sargodha

    Sargodha, Punjab Province, 40100, Pakistan